DK2569007T3 - Vaccine mod mycoplasma hyopneumoniae egnet til administration i nærvær af maternalt afledte antistoffer - Google Patents

Vaccine mod mycoplasma hyopneumoniae egnet til administration i nærvær af maternalt afledte antistoffer Download PDF

Info

Publication number
DK2569007T3
DK2569007T3 DK11720079.0T DK11720079T DK2569007T3 DK 2569007 T3 DK2569007 T3 DK 2569007T3 DK 11720079 T DK11720079 T DK 11720079T DK 2569007 T3 DK2569007 T3 DK 2569007T3
Authority
DK
Denmark
Prior art keywords
vaccine
mycoplasma hyopneumoniae
administration
derived antibodies
mhyo
Prior art date
Application number
DK11720079.0T
Other languages
English (en)
Inventor
Maarten Hendrik Witvliet
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42667916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2569007(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK2569007T3 publication Critical patent/DK2569007T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Claims (5)

  1. VACCINE MOD MYCOPLASMA HYOPNEUMONIAE EGNET TIL ADMINISTRATION I NÆRVÆR AF MATERNALT AFLEDTE ANTISTOFFER
    1. Vaccine, der omfatter inaktiverede Mycoplasma hyopneumoniae-antigener til intradermal indgivelse til et dyr, der har matemalt afledte antistoffer rettet mod Mycoplasma hyopneumoniae, til anvendelse i en fremgangsmåde til aktivt at beskytte dyret mod en sygdom, der stammer fra en infektion med Mycoplasma hyopneumoniae.
  2. 2. Vaccine til anvendelse ifølge krav 1, kendetegnet ved, at den inducerer aktiv beskyttelse efter en enkelt vaccination.
  3. 3. Vaccine til anvendelse ifølge et hvilket som helst af de foregående krav, kendetegnet ved, at den er til administration til dyr med en alder på mellem 10 og 18 dage.
  4. 4. Vaccine til anvendelse ifølge krav 1, kendetegnet ved, at vaccinen omfatter vitamin E-acetat som et hjælpestof.
  5. 5. Anvendelse af inaktiverede Mycoplasma hyopneumoniae-antigener til fremstilling af en vaccine til intradermal indgivelse til et dyr, der har matemalt afledte antistoffer mod Mycoplasma hyopneumoniae i sit serum, for at beskytte dyret mod en sygdom, der stammer fra en infektion med Mycoplasma hyopneumoniae.
DK11720079.0T 2010-05-11 2011-05-10 Vaccine mod mycoplasma hyopneumoniae egnet til administration i nærvær af maternalt afledte antistoffer DK2569007T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33350210P 2010-05-11 2010-05-11
EP10162580 2010-05-11
PCT/EP2011/057463 WO2011141443A1 (en) 2010-05-11 2011-05-10 Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Publications (1)

Publication Number Publication Date
DK2569007T3 true DK2569007T3 (da) 2016-01-25

Family

ID=42667916

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11720079.0T DK2569007T3 (da) 2010-05-11 2011-05-10 Vaccine mod mycoplasma hyopneumoniae egnet til administration i nærvær af maternalt afledte antistoffer

Country Status (7)

Country Link
US (1) US20130064852A1 (da)
EP (1) EP2569007B1 (da)
JP (1) JP5865350B2 (da)
DK (1) DK2569007T3 (da)
ES (1) ES2559445T3 (da)
PL (1) PL2569007T3 (da)
WO (1) WO2011141443A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
WO2014176436A1 (en) 2013-04-24 2014-10-30 The General Hospital Corporation System and method for estimating high time-frequency resolution eeg spectrograms to monitor patient state

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273022T1 (de) 1992-09-28 2004-08-15 Wyeth Corp Verfahren zur verstärkung zellularer immunantworten
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
DK2027873T3 (da) 2001-07-02 2015-11-09 Zoetis Services Llc Enkeltdosisvaccination med mycoplasma hyopneumoniae
NZ532866A (en) 2001-10-12 2005-12-23 Felton International Inc Jet injector with hand piece
EP1515763B1 (en) 2002-06-10 2011-08-17 Intervet International BV Needle-less injector
NZ545289A (en) 2003-07-24 2008-05-30 Merial Ltd Vaccine formulations comprising an oil-in-water emulsion
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
WO2007103042A2 (en) 2006-03-03 2007-09-13 Merial Limited Mycoplasma hyopneumoniae vaccine
EA017441B1 (ru) * 2006-06-15 2012-12-28 Новартис Аг Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗

Also Published As

Publication number Publication date
ES2559445T3 (es) 2016-02-12
WO2011141443A1 (en) 2011-11-17
EP2569007A1 (en) 2013-03-20
JP5865350B2 (ja) 2016-02-17
US20130064852A1 (en) 2013-03-14
JP2013526504A (ja) 2013-06-24
EP2569007B1 (en) 2015-10-14
PL2569007T3 (pl) 2016-04-29

Similar Documents

Publication Publication Date Title
KR101315092B1 (ko) 로소니아 인트라셀룰라리스를 포함하는 면역원성 조성물
US10918711B2 (en) Composition comprising antigens and a mucosal adjuvant and a method for using
KR20070050499A (ko) 렙토스피라 브라티슬라바 및 그 밖의 다른 병원체에 대한다가 개 백신
JP5789897B2 (ja) マイコプラズマ・ボビス ワクチン
DK2569007T3 (da) Vaccine mod mycoplasma hyopneumoniae egnet til administration i nærvær af maternalt afledte antistoffer
EP3432922B1 (en) Orf virus-based platform for vaccine delivery
BR112015012711B1 (pt) Método para preparar uma composição imunogênica para o tratamento e/ou a profilaxia de infecções por mycoplasma
ES2808673T3 (es) Composición inmunogénica que comprende antígenos de micoplasma
AU2013351213B2 (en) Vaccine to protect a ruminant against pneumonia caused by Pasteurella multocida
JP6484241B2 (ja) ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン
JP7425728B2 (ja) レンサ球菌感染防御のためのワクチン
CN107206062B (zh) 用于针对猪中亚临床劳森氏菌感染的疫苗
EP2976102A1 (en) Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
Nimmanapalli et al. Vaccines the tugboat for prevention-based animal production
CN107249625B (zh) 用于针对猪中亚临床劳森氏菌感染的疫苗
JP5865839B2 (ja) 粘膜アジュバント組成物
Anusha et al. Strategies and Techniques for Enhancing Fish Health and Averting Disease Outbreaks in Aquaculture Settings through the Use of Vaccination: A Review
EP2076280B1 (en) Feline influenza vaccine and method of use